BioSpace News Archive

Sangamo Therapeutics recently filed a notice with the U.S. Securities and Exchange Commission (SEC) describing a data security breach. The incident underlines what appears to be a trend of cyber thieves attacking the biopharma industry.

Milestone achieved under the highly successful strategic alliance Evotec and Bayer entered in October 2012.

Breakthrough addresses huge problem in management of health information; will advance ability of health professionals to practice precision medicine and ensure patients receive right treatment at right time.

Technology will be used to progress Fusion’s pipeline of alpha therapeutics for the treatment of cancers

INT-1B3 targets multiple hallmarks of cancer as a single agent resulting in immune-system activation, tumor regression and pronounced long term immunity

$100 Million Project Will Enable Researchers to Better Understand HIV in Nigeria

Canopy Growth Corporation and the Yukon Liquor Corporation announced that the Company has entered into an agreement to supply Yukon with high-quality cannabis products to serve the upcoming adult retail market.

Facing unprecedented challenges associated with Brexit, on 13 April the UK’s major clinical research organizations (CROs) met with the Rt Hon Hilary Benn (Labour - Leeds Central) to tour Covance’s research facilities in Leeds and discuss the implications of the impending separation from the European Union.

Second Synthetic Biotic™ program to move into clinical studies in 2018

Syngenta announced today that a new insecticide active ingredient with a novel mode of action to address resistance in the control of malaria vectors is entering the early development phase.